Nautilus Biotechnology, Inc. · NASDAQ:NAUT
Perceptive Advisors LLC reported a 10.10% stake in Nautilus Biotechnology, Inc. (Schedule 13D/A)
Event Jun 20, 2025 · Filed Jun 24, 2025
Perceptive Advisors LLC reported a 10.10% stake in Nautilus Biotechnology, Inc., 12,815,113 shares, with active intent on Jun 20, 2025. Filed Jun 24, 2025 (Schedule 13D/A).
- Stake
- 10.10%
- Shares
- 12,815,113
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 10.10% | 12,815,113 |
| Joseph Edelman | 10.10% | 12,815,113 |
| Perceptive Life Sciences Master Fund, Ltd. | 10.00% | 12,649,253 |
Source
Related
- Nautilus Biotechnology, Inc.
- Perceptive Advisors LLC
- Nautilus Biotechnology, Inc. shareholders
- Schedule 13D/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Jan 31, 2025
- Schedule 13D/A · Andreessen Marc L · Sep 11, 2026
- Schedule 13D/A · Andreessen Marc L · Aug 28, 2026
- Schedule 13D/A · Andreessen Marc L · Jun 30, 2026
- Form 4 · AH Bio Fund II, L.P. · Jun 4, 2026
- Schedule 13D/A · Andreessen Marc L · Jun 4, 2026